Europe - Euronext Milan - BIT:1JNJ - US4781601046 - Common Stock
Taking everything into account, 1JNJ scores 6 out of 10 in our fundamental rating. 1JNJ was compared to 55 industry peers in the Pharmaceuticals industry. While 1JNJ belongs to the best of the industry regarding profitability, there are some minor concerns on its financial health. 1JNJ has a correct valuation and a medium growth rate.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 13.03% | ||
| ROE | 31.69% | ||
| ROIC | 14.68% |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 27% | ||
| PM (TTM) | 27.26% | ||
| GM | 68.14% |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.55 | ||
| Debt/FCF | 2.34 | ||
| Altman-Z | 4.75 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.07 | ||
| Quick Ratio | 0.8 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 20.74 | ||
| Fwd PE | 18.63 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 26.48 | ||
| EV/EBITDA | 15.67 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.37% |
ChartMill assigns a fundamental rating of 6 / 10 to 1JNJ.MI.
ChartMill assigns a valuation rating of 4 / 10 to JOHNSON & JOHNSON (1JNJ.MI). This can be considered as Fairly Valued.
JOHNSON & JOHNSON (1JNJ.MI) has a profitability rating of 7 / 10.
The Price/Earnings (PE) ratio for JOHNSON & JOHNSON (1JNJ.MI) is 20.74 and the Price/Book (PB) ratio is 6.55.
The financial health rating of JOHNSON & JOHNSON (1JNJ.MI) is 6 / 10.